Pasqal Holding S.A. Ordinary Share

The stock remains in a damaged long-term downtrend, trading below both the 50-day and 200-day moving averages. It is also sitting near the 52-week low after a sharp drawdown from the 52-week high of 24.69, so the regime still favors caution until the trend base improves.

Street coverage is thin but constructive: the only recent initiation was Roth Capital starting PSQL at Buy with a $20 target. That target sits well above the current share price and implies meaningful upside, but the lack of a broader consensus keeps the signal early-stage rather than confirmed.

No earnings date is set, and there is no quarterly beat/miss history to anchor expectations. The key watch item is whether losses narrow from the current negative EPS profile, with next-year EPS still projected at -0.35, which suggests the market will focus on execution and cash burn.

No recent insider transactions. With no discretionary buying or selling on record, there is no insider signal to offset the stock’s weak price trend or to suggest management is making a visible timing call.

Profitability remains negative, with trailing EPS at -0.51 and free cash flow of -13.45 million in fiscal 2025. The balance sheet is a positive offset: 70.93 million in cash against 7.64 million of debt leaves 63.29 million in net cash, giving the company runway while it scales.

Pasqal is a niche quantum-computing hardware and platform name, so it competes more on technology differentiation than on current earnings power. On valuation, the market is still pricing it as a high-risk growth story, with no meaningful earnings multiple support and a target far above the current quote.